Rss/rsscompary_1273.aspxprbd.net - Submit Press Release and get wide media coverageCopyright 2011 prbdhttps://www.prbd.net/news_5511.aspxKey Patent Covers Fundamental Methods for Producing RPE Cells from Embryonic Stem Cells Including IP Used in Phase I Trial to Treat Patients with Stargardt's Macular Dystrophy.Sat, 19 Jun 2010 00:00:00 GMThttps://www.prbd.net/news_5241.aspxAccess to Federal Funding Could Accelerate Clinical DevelopmentSat, 12 Jun 2010 00:00:00 GMThttps://www.prbd.net/news_3643.aspxWORCESTER, MA – (BUSINESS WIRE) Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC) announced today that it has completed key animal studies in connection with its Phase I multicenter study using embryonic stem cell derived Retinal Pigment Epithelium (RPE) cells to treat patients with Stargardt's Macular Dystrophy (SMD), for which it filed an Investigational New Drug Application (IND) with the US Food and Drug Administration (FDA) in November.Mon, 26 Apr 2010 00:00:00 GMThttps://www.prbd.net/news_2572.aspxWORCESTER -- Advanced Cell Technology, Inc. (OTCBB: ACTC), a biotechnology company applying cellular technology in the field of regenerative medicine, announced that company Chairman and Chief Executive Officer William M. Caldwell IV was interviewed yesterday on Bloomberg Radio's popular mid-day program, The Hays Advantage, hosted by Kathleen Hays.Sun, 21 Mar 2010 00:00:00 GMThttps://www.prbd.net/news_2155.aspxThe National Institutes of Health is proposing to expand its definition of human embryonic stem cells, enabling the university researchers it finances to work with cells derived from a very early human egg.Sat, 06 Mar 2010 00:00:00 GMThttps://www.prbd.net/news_2154.aspxThe National Institutes of Health is proposing a small change to the definition of "human embryonic stem cell" that could have a big effect on their long-term ability to lead to cures for a variety of diseases.Sat, 06 Mar 2010 00:00:00 GMT